#HAT medium

Immunological Applications

Hybridoma cells survive in HAT medium because they:

Survival in HAT environment demands functional purine and pyrimidine salvage enzymes inherited from normal B parent. B lymphocytes express HPRT1 locus on X chromosome encoding 24 kDa hypoxanthine-guanine phosphoribosyltransferase that catalyzes phosphoribosyl transfer from PRPP to hypoxanthine yielding IMP plus pyrophosphate and to guanine yielding GMP, bypassing de novo steps requiring folate. They also express cytosolic thymidine kinase 1 cell-cycle regulated peaking in S phase and mitochondrial kinase 2 constitutive, phosphorylating thymidine supplied in medium to TMP using ATP. Hybridoma cells retain active alleles, enabling uptake of exogenous bases via equilibrative nucleoside transporters ENT1 and ENT2 and concentrative transporters CNT, generating nucleotides sufficient for DNA synthesis even when de novo synthesis ablated by aminopterin. Energy charge maintained allowing progression through G1/S checkpoint via cyclin E CDK2. Myeloma parents selected with 8-azaguanine lack HGPRT activity, cannot recycle hypoxanthine, undergo purine starvation, decrease in ATP and GTP pools activates p53 and causes mitochondrial depolarization. Unfused B cells possess salvage enzymes but inherently short lived due to withdrawal of BAFF and CD40L, undergoing apoptosis within seven days, leaving only hybrids as long-term proliferating population capable of indefinite expansion in selective medium.

Ref: Janeway Immunobiology salvage pathway HGPRT; Freshney Animal Cell Culture hybrids survive HAT via HGPRT TK from B cell.

View Details

Immunological Applications

Aminopterin in HAT medium functions by:

Aminopterin classifies as antifolate antimetabolite structurally analogous to folic acid with pteridine ring substitution preventing enzymatic reduction. Dihydrofolate reductase normally catalyzes NADPH dependent reduction of dihydrofolate to tetrahydrofolate, central one-carbon carrier crucial for biosynthesis. Tetrahydrofolate derivatives required at two distinct steps: 10-formyl tetrahydrofolate donates formyl groups to glycinamide ribonucleotide transformylase and aminoimidazole carboxamide ribonucleotide transformylase in de novo purine pathway synthesizing inosine monophosphate precursor to adenine and guanine nucleotides, and 5,10-methylene tetrahydrofolate provides methyl group to thymidylate synthase converting deoxyuridine monophosphate to thymidine monophosphate essential for DNA replication. Aminopterin competitive inhibition depletes all tetrahydrofolate pools, halts purine and thymidine triphosphate production, cellular ATP drops, AMPK activated, p53 stabilization triggers apoptosis within hours. Rapidly proliferating lymphocytes depend heavily on de novo route because salvage alone insufficient during S phase. Provision of hypoxanthine and thymidine allows salvage-competent cells to circumvent block via HGPRT and TK, explaining selective toxicity exploited in hybridoma selection and historically in cancer chemotherapy similar to methotrexate.

Ref: Goodman & Gilman Pharmacol 13th ed DHFR antifolate; Lodish MBoC 9th ed Fig 7-32 aminopterin blocks de novo purine thymidylate.

View Details

Immunological Applications

HAT medium contains:

HAT selective medium developed by John Littlefield in 1964 exploits metabolic auxotrophy to isolate somatic hybrids based on nucleotide salvage capability. Base medium DMEM or RPMI supplemented with fetal bovine serum provides carbon source, but three selective additives define HAT: hypoxanthine at 100 micromolar serving as purine base for salvage via hypoxanthine-guanine phosphoribosyltransferase converting to inosine monophosphate using phosphoribosyl pyrophosphate donor, thymidine at 16 micromolar supplying pyrimidine salvage substrate for thymidine kinase isoforms TK1 cytosolic and TK2 mitochondrial phosphorylating to thymidine monophosphate, and aminopterin at 0.4 micromolar acting as high-affinity folate antagonist. Aminopterin binds dihydrofolate reductase at picomolar Ki, preventing regeneration of tetrahydrofolate required for one-carbon transfer reactions in purine ring biosynthesis and thymidylate formation. De novo nucleotide synthesis collapses causing dNTP pool depletion, replication fork stalling,ATR mediated checkpoint activation, and S phase arrest. Only cells expressing both salvage enzymes bypass block by recycling exogenous bases, creating powerful negative selection for hybrids while eliminating auxotrophic myeloma background that lacks HGPRT.

Ref: Littlefield Science 1964 145:709 HAT selection; Szybalski Biochem Pharmacol HAT hypoxanthine aminopterin thymidine composition.

View Details

Immunological Applications

Myeloma cells used in hybridoma technology are selected to be:

Trastuzumab humanized IgG1 kappa mAb 148 kDa targets HER2 proto-oncogene extracellular domain IV juxtamembrane receptor overexpressed due ERBB2 amplification 17q12 20 percent breast gastric cancers poor prognosis. HER2 no known ligand but dimerizes HER1 HER2 HER3 after EGF binding autophosphorylating intracellular tyrosines Tyr1221 Tyr1222 recruiting Grb2 Shc activating PI3K Akt survival phosphorylating Bad Forkhead preventing apoptosis plus RAS RAF MEK ERK proliferation cyclin D1. Trastuzumab binds KD 5 nM sterically hindering dimerization preventing proteolytic cleavage shedding ECD generating constitutively active p95 truncated lacking ectodomain and inducing internalization clathrin-mediated requiring c-Cbl E3 ubiquitin ligase ubiquitination lysosomal degradation reducing surface density. Fc human IgG1 engages Fc gamma RIIIa CD16a NK cells triggering perforin granzyme ADCC and macrophage ADCP phagocytosis. Combination taxane docetaxel increased response 32 to 50 percent overall survival prolongation establishing HER2 testing companion diagnostic immunohistochemistry score 3+ FISH ratio >2.0 guiding patient selection achieving paradigm targeted immunotherapy solid tumors effective safe with cardiac monitoring due occasional LV dysfunction.

Ref: NEJM Trastuzumab HER2 Mechanism Slamon 2001 Clinical; FDA Herceptin Package Insert MOA Description; Janeway ADCC Trastuzumab Immune Mechanism NK Chapter 14.

View Details

Immunological Applications

Hybridoma cells survive in HAT medium because they:

Handling hybridoma cultures demands sensitive high-throughput detection secreted immunoglobulin microgram per mL among abundant serum proteins albumin bovine Ig. ELISA screening provides optimal format 96-well polystyrene plates coated purified antigen 1 ug/mL overnight 4 degrees passive hydrophobic adsorption van der Waals blocked 2 percent BSA 5 percent nonfat milk PBS preventing nonspecific binding plastic. Culture supernatant 50 uL added incubates 1h 37 degrees enabling specific binding Fab antigen interaction affinity association rate 10^5 per molar per second. After three washes PBS 0.05 percent Tween removing unbound proteins immune complex remains due high avidity. HRP conjugated goat anti-mouse IgG secondary binds Fc region captured mouse antibody. Substrate tetramethylbenzidine oxidized peroxidase H2O2 generates blue radical 650 nm converting yellow diimine after sulfuric acid stop absorbance 450 nm proportional titer. Purification Protein A Staphylococcus aureus or Protein G Streptococcus binds Fc CH2-CH3 interface neutral pH 7.4 affinity 10^-8 M eluting pure IgG pH 3.0 glycine followed dialysis concentration ultrafiltration yielding clinical-grade monoclonal reagent therapeutically diagnostically used screening high producers early.

Ref: Janeway Hybridoma Screening ELISA Technique Protocol; Alberts Protein A Purification Antibody Methods Chapter 8; Lodish Antibody Purification Immunotechniques Handbook Methods.

View Details

Immunological Applications

Aminopterin in HAT medium functions by:

Antibody specificity arises exquisite three-dimensional complementarity between paratope heavy light chain variable domains epitope antigen surface determining binding free energy selectivity. Variable domains each contribute three complementarity-determining regions CDR1 CDR2 CDR3 loops supported conserved framework beta sheet Ig fold creating pocket groove protruding loop accommodating antigen features charged arginine aspartate hydrophobic tryptophan phenylalanine patches hydrogen bond donors carbohydrate. Binding stabilized hydrogen bonds CDR backbone carbonyl antigen side chain salt bridges arginine aspartate van der Waals contacts burying 600-900 square angstrom entropic gain displacing ordered water. Equilibrium dissociation constants after affinity maturation involving activation-induced cytidine deaminase mediated somatic hypermutation point mutations rate 10^-3 per base division selection improved binding germinal center dark zone light zone cycle follicular dendritic cell antigen presentation T follicular helper CD40 ligand signals reach picomolar 10^-11 M. Specific antibody discriminates closely related antigens differing single amino acid HER1 vs HER2 despite 40 percent homology or dopamine vs norepinephrine preventing cross-reactivity contributing safety therapeutic monoclonal targeting CD20 without depleting CD22 or HER2 without affecting EGFR. Specificity underpins diagnostic accuracy toxin neutralization blocking receptor interaction therapeutic targeting.

Ref: Janeway Antibody Specificity CDR Structure Affinity Chapter 5; NCBI Antibody Antigen Recognition Principles; Alberts Immunoglobulin Variable Region Specificity Chapter 24.

View Details

Immunological Applications

HAT medium contains:

HAT medium intelligent metabolic selection exploiting two distinct pathways nucleotide biosynthesis de novo synthesis requiring tetrahydrofolate one-carbon donor and salvage reusing preformed purines pyrimidines. Aminopterin potent folic acid analog competitively inhibits dihydrofolate reductase converting dihydrofolate tetrahydrofolate Ki 0.03 nM blocking regeneration tetrahydrofolate required thymidylate synthase converting dUMP dTMP purine enzymes GAR transformylase AICAR transformylase shutting de novo purine thymidine synthesis hours. Cell survival then depends entirely salvage enzymes HPRT converting hypoxanthine supplied IMP thymidine kinase phosphorylating thymidine TMP. Myeloma partners deliberately selected HPRT-negative mutants via resistance 8-azaguanine analog kills HPRT-proficient cells incorporating toxic nucleotide cannot utilize hypoxanthine therefore die aminopterin presence 48h. Primary B cells naturally expire short lifespan 3 days. Only heterokaryons inheriting functional HPRT gene B cell immortal proliferation program myeloma proliferate forming visible colonies 10-14 days post fusion counted inverted microscope. Optimized formulation hypoxanthine 100 uM aminopterin 0.4 uM thymidine 16 uM RPMI 1640 20 percent FBS supporting selective growth hybridomas.

Ref: Littlefield Science 1964 HAT Selection Classic; Janeway Immunobiology HAT Composition Components Chapter 2; Lodish Cell Culture HAT Selection Principle Media.

View Details

Basic Applied Biology

HAT medium selects hybridoma cells based on:

HAT medium selection developed by John Littlefield in 1964 exploits differential nucleotide anabolism pathways to isolate hybrid cells from mixture of parental populations. De novo purine and pyrimidine synthesis requires tetrahydrofolate-dependent enzymes, specifically aminopterin, a folate analog, competitively inhibits dihydrofolate reductase DHFR blocking de novo pathway. Alternative salvage pathway recycles hypoxanthine via hypoxanthine-guanine phosphoribosyltransferase HGPRT converting to IMP and thymidine via thymidine kinase TK to TMP, bypassing blocked de novo routes. Myeloma partners engineered to lack HGPRT through 8-azaguanine selection or TK deficiency via bromodeoxyuridine selection cannot utilize salvage and therefore die in HAT containing hypoxanthine, aminopterin and thymidine. B lymphocytes naturally express HGPRT and TK but are mortal in culture, senescing within days. Only hybrid cells inheriting immortal growth from myeloma and salvage enzymes from B cell survive after 10 to 14 days culture. Subsequent cloning by limiting dilution at 0.5 cell per well ensures monoclonality. This biochemical selection remains gold standard because de novo dependence versus salvage provides elegant genetic selection mechanism.

Ref: Littlefield Science 1964 Selection of hybrids; Abbas Immunology 10th ed. HAT selection; Alberts Ch nucleotide metabolism salvage.

View Details